Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1212-1213
doi: 10.1161/CIRCULATIONAHA.108.808584
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finn, A. V.
Right arrow Articles by Leinbach, R. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Finn, A. V.
Right arrow Articles by Leinbach, R. C.
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other

(Circulation. 2008;118:1212-1213.)
© 2008 American Heart Association, Inc.


In Memoriam

Herman Kalman Gold, MD

1940–2008

Aloke V. Finn, MD; Robert C. Leinbach, MD

From the Department of Internal Medicine, Emory University School of Medicine, Atlanta, Ga (A.V.F.) and Harvard Medical School/Massachusetts General Hospital, Boston (R.C.L.).

Correspondence to Aloke V. Finn, MD, Department of Internal Medicine, Emory University School of Medicine, Emory Crawford Long Hospital, 550 Peachtree St NE, Atlanta, GA 30308. E-mail avfinn@emory.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Dr Herman K. Gold, Associate Professor of Medicine, Harvard Medical School, Boston, Mass, died on March 1, 2008, at the Massachusetts General Hospital (MGH) of complications related to acute myelogenous leukemia. He was 67 years old. Dr Gold served for 37 years as staff physician and interventional cardiologist in the Department of Cardiology at MGH and was responsible for groundbreaking research in the use of fibrinolytic agents and subsequently glycoprotein IIb/IIIa inhibitors in the treatment of myocardial infarction.

Dr Gold was born in Newport News, Va, the son of Jonah and Miriam Gold. His life was from early childhood shaped by medicine, a recognition of the role it played in saving his own life, which drove his passion, hope, and tireless energy in the pursuit of medical advances and clinical excellence to save others. Two indelible childhood events fueled his desire to become a physician. As a child, he contracted scarlet fever. During wartime, penicillin was rationed, and the family was only able to obtain enough for a few doses. He recalled that every night, his parents would boil his urine to collect enough penicillin for the next day’s treatment. Later, at the age of 9, he contracted bulbar polio, which prevented him from swallowing properly for nearly 2 years. These two experiences imprinted in him an appreciation for good health and a feeling of personal obligation as a physician to try sometimes unconventional treatments in an effort to cure patients’ ills.

Dr Gold received his BS from the College . . . [Full Text of this Article]